Genetic prenatal and preimplantation diagnosis of trinucleotide repeat disorders

Expert Review of Neurotherapeutics

Volumn 2, Issue 4, 2002, Pages 561-572

  Dean, Nicola L ^a   Ao, Asangla ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Fragile X syndrome; Huntington's disease; Myotonic dystrophy; Preimplantation genetic diagnosis; Prenatal diagnosis; Trinucleotide repeats

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; DENTATORUBROPALLIDOLUYSIAN ATROPHY; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MEDICAL ETHICS; MENTAL DISEASE; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; PRENATAL DIAGNOSIS; REVIEW; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT; X CHROMOSOME LINKED DISORDER;

EID: 0036304069     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.2.4.561     Document Type: Review

References (91)

1. Trinucleotide repeats: Mechanisms and pathophysiology
2. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington's disease-like 2
3. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein
4. Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells
5. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma
6. Maturation in vitro of human ovarian oocytes
7. Birth of a normal girl after in vitro fertilisation and preimplantation diagnostic testing for cystic fibrosis
8. Impact of reducing the number of embryos transferred from three to two in women under the age of 35 who produced three or more high quality embryos
9. The development of preimplantation genetic diagnosis for myotonic dystrophy using multiplex fluorescent polymerase chain reaction and its dinical application
10. PGD in the lab for triplet repeat diseases-myotonic dystrophy, Huntington's disease and Fragile-X syndrome
11. Juvenile onset Huntington's disease - Clinical and research perspectives
12. First-trimester prenatal diagnosis for Huntington's disease with DNA probes
13. Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker
14. Prenatal, presymptomatic and diagnostic testing with direct mutation analysis in Huntington's disease
15. Different options for prenatal testing for Huntington's disease using DNA probes
16. Preimplantation diagnosis for Huntington's disease (HD): Clinical application and analysis of the HD expansion in affected embryos
17. Preimplantation genetic testing for Huntington's disease and certain other dominantly inherited diseases
18. Prenatal diagnosis of X-linked spinal and bulbar muscular atrophy in a Greek family
19. Preimplantation genetic diagnosis for spinal and bulbar muscular atrophy (SBMA)
20. Prenatal diagnosis of Machado-Joseph disease by direct mutation analysis
21. Spinocerebellar ataxia Type 7: A distinctive form of autosomal dominant cerebellar ataxia with retinopathy and marked genetic anticipation
22. Reproductive counselling for women with myotonic dystrophy
23. Molecular basis of myotonic dystrophy: Expansion of trinucleotide (CTG) repeat at 3′ end of a transcript encoding a protein kinase family member
24. Myotonic dystrophy: An unstable CTG repeat in the 3′ untranslated region of the gene
25. Letter: Prenatal prediction of myotonic dystrophy
26. The secretor locus as a marker for prenatal prediction of myotonic dystrophy (DM)
27. First-trimester prediction in fetus at risk for myotonic dystrophy
28. Prenatal diagnosis of myotonic dystrophy using closely linked flanking markers
29. Predictive diagnosis of myotonic dystrophy with flanking microsarellite markers
30. Prenatal diagnosis of myotonic dystrophy by direct mutation analysis
31. Direct detection of expanded trinucleotide repeats using PCR and DNA hybridization techniques
32. Characterization of large CTG repeat expansions in myotonic dystrophy alleles using PCR
33. Clinical application of preimplantation diagnosis for myotonic dystrophy
34. Fluorescent PCR and automated fragment analysis for the clinical application of preimplantation genetic diagnosis of myotonic dystrophy (Steinerts disease)
35. Fragile X syndrome: Growth, development and intellectual function
36. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
37. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome
38. DNA methylation represses FMR-1 transcription in fragile X syndrome
39. Experience with prenatal fragile X detection
40. An assessment of the use of flanking DNA markers for fra(X) syndrome carrier detection and prenatal diagnosis
41. Difficult diagnosis of the fragile X syndrome made possible by direct detection of DNA mutations
42. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation
43. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence
44. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test
45. Accelerated prenatal diagnosis of Fragile X syndrome by polymerase chain reaction restriction fragment detection
46. RS46 (DXS548) genotyping of reproductive cells: Approaching preimplantation testing of the fragile-X syndrome
47. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm
48. Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers
49. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG
50. Characterization of the full fragile X syndrome mutation in fetal gametes
51. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
52. Prenatal diagnosis of Friedreich ataxia
53. Prenatal diagnosis of Friedreichs ataxia
54. Trinudeotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation
55. Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: Analysis of four FRAXE families with mild mental retardation in males
56. FRAXE mutation analysis in three Spanish families
57. High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression
58. Expand long PCR for fragile X mutation detection
59. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study-preliminary data
60. Controlling misdiagnosis errors in preimplantation genetic diagnosis: A comprehensive model encompassing extrinsic and intrinsic sources of error
61. Preimplantation diagnosis: A patient perspective
62. Prenatal diagnosis of fragile X syndrome
63. Prenatal fragile X detection using cytoplasmic and nuclear-specific monoclonal antibodies
64. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers
65. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
66. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's Disease chromosomes
67. Trinucleotide repeat length instability and age of onset in Huntington's disease
68. Analysis of the CAG repeat expansion in spinocerebellar ataxia Type 1: Evidence for a possible mechanism predisposing to instability
69. Expansion of an unstable trinudeotide CAG repeat in spinocerebellar ataxia Type 1
70. Cloning of the gene for spinocerebellar ataxia Type 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats and high instability
71. Identification of the SCA2 gene: Moderate expansion of a normally biallelic trinucleotide repeat
72. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
73. Correlation between CAG repeat length and clinical features in Machado-Joseph disease
74. Episodic ataxia Type 2 (EA2) and spinocerebellar ataxia 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p
75. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel
76. Cloning of the SCA7 gene reveals a highly stable CAG unstable expansion
77. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype
78. Unstable expansion of CAG repeat in dentatorubral-pallidoluysian atrophy (DRPLA)
79. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atroph
80. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy
81. An unstable triplet repeat in a gene related to myotonic muscular dystrophy
82. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)
83. Massive CTG expansions and deletions may reduce penetrance of spinocerebellar ataxia Type 8
84. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PP2R2B is associated with SCA12
85. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: A study of an Indian family
86. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
87. Fragile X syndrome: Unique genetics of the heritable unstable element
88. Characterisation of a new rare fragile site easily confused with the fragile X
89. The Friedreich ataxia FAA triplet repeat: Premutation and normal alleles